Literature DB >> 19804515

Electrophysiologic characteristics of wide QRS complexes during pharmacologic termination of sustained supraventricular tachycardias with verapamil and adenosine: observations from electrophysiologic study.

Cengizhan Türkoğlu1, Muzaffer Oztürk, Farid Aliyev, Inci Firatli, Nilgün Incesoy.   

Abstract

BACKGROUND: In this study we evaluate wide QRS complexes observed during pharmacologic termination of supraventricular tachycardias.
METHODS: Patients with supraventricular tachycardia, undergoing electrophysiologic study were enrolled. 12 mg of adenosine or 10 mg of verapamil were administered during tachycardia, under continuous monitoring of intaracardiac and surface electrocardiograms. Electrocardiographic features of ventricular ectopy were noted.
RESULTS: Seventy-four patients were enrolled. 48 patients were randomized to adenosine and 26 to verapamil. Five different appearance patterns of ventricular ectopy were observed during termination of tachycardias. All wide QRS complexes were of ventricular origin and all of them were observed during the termination of tachycardia. Adenosine more frequently resulted in appearance of ventricular beats (15.4% vs 41.7%, P = 0.003), and this was more frequently observed in patients with atrioventricular nodal reentrant tachycardia. Patients with ventricular beats were younger than those without, in both, verapamil (47.5 +/- 15.6 vs 65.0 +/- 8.8 years, P = 0.04) and adenosine (40.9 +/- 13.8 vs 49.7 +/- 16.8, P = 0.03) groups. Left bundle branch block (LBBB)/superior axis morphology was most frequent morphology in adenosine group (55%). Two of 4 patients in verapamil group displayed LBBB/inferior axis QRS morphology and another 2 patients displayed LBBB/superior axis morphology.
CONCLUSIONS: Noncatheter induced, five different appearance patterns and four distinct morphologies of ventricular origin were observed. Most of them do not directly terminate tachycardia, but are associated with its termination and are not observed in ongoing tachycardia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804515      PMCID: PMC6932567          DOI: 10.1111/j.1542-474X.2009.00329.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  11 in total

1.  Transient ventricular tachycardia following the Valsalva maneuver in a patient with paroxysmal atrial tachycardia.

Authors:  G ENTWISLE; W HOLLANDER
Journal:  Am Heart J       Date:  1956-11       Impact factor: 4.749

2.  Experimental study on ventricular extrasystoles provoked by vagal stimulation.

Authors:  D SCHERF; S BLUMENFELD; M YILDIZ
Journal:  Am Heart J       Date:  1961-11       Impact factor: 4.749

3.  Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.

Authors:  J P DiMarco; W Miles; M Akhtar; S Milstein; A D Sharma; E Platia; B McGovern; M M Scheinman; W C Govier
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

4.  Right and left ventricular outflow tract tachycardias: evidence for a common electrophysiologic mechanism.

Authors:  Sei Iwai; Daniel J Cantillon; Robert J Kim; Steven M Markowitz; Suneet Mittal; Kenneth M Stein; Bindi K Shah; Ravi K Yarlagadda; Jim W Cheung; Vivian R Tan; Bruce B Lerman
Journal:  J Cardiovasc Electrophysiol       Date:  2006-06-27

5.  Verapamil induced premature ventricular beats before reversion of supraventricular tachycardia.

Authors:  J Vohra; T Peter; D Hunt; G Sloman
Journal:  Br Heart J       Date:  1974-12

Review 6.  Mechanisms of idiopathic left ventricular tachycardia.

Authors:  B B Lerman; K M Stein; S M Markowitz
Journal:  J Cardiovasc Electrophysiol       Date:  1997-05

7.  Adenosine increases sympathetic nerve traffic in humans.

Authors:  I Biaggioni; T J Killian; R Mosqueda-Garcia; R M Robertson; D Robertson
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

8.  Adenosine induced ventricular arrhythmias in the emergency room.

Authors:  H L Tan; H H Spekhorst; R J Peters; A A Wilde
Journal:  Pacing Clin Electrophysiol       Date:  2001-04       Impact factor: 1.976

9.  Clinical significance of wide QRS complexes at the termination of paroxysmal supraventricular tachycardias.

Authors:  Yasumi Endoh; Hirotsugu Atarashi; Hirokazu Hayakawa; Kouichi Nagasawa; Hiroshi Kishida; Teruo Takano
Journal:  J Nippon Med Sch       Date:  2002-12       Impact factor: 0.920

10.  Verapamil-induced polymorphous ventricular tachycardia.

Authors:  S L Winters; P Schweitzer; J Kupersmith; J A Gomes
Journal:  J Am Coll Cardiol       Date:  1985-07       Impact factor: 24.094

View more
  3 in total

Review 1.  Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.

Authors:  Samer Alabed; Ammar Sabouni; Rui Providencia; Edmond Atallah; Mohammed Qintar; Timothy Ja Chico
Journal:  Cochrane Database Syst Rev       Date:  2017-10-12

Review 2.  In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia.

Authors:  Farrukh Ahmad; Majdi Abu Sneineh; Ravi S Patel; Sai Rohit Reddy; Adiona Llukmani; Ayat Hashim; Dana R Haddad; Domonick K Gordon
Journal:  Cureus       Date:  2021-06-07

Review 3.  Fractional flow reserve-guided percutaneous coronary intervention: where to after FAME 2?

Authors:  Tim P van de Hoef; Martijn Meuwissen; Jan J Piek
Journal:  Vasc Health Risk Manag       Date:  2015-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.